Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 89.5K | Oct 1, 2024 | Direct | ||
TFF Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 84.7K | Sep 29, 2022 | Direct | ||
TFF Pharmaceuticals, Inc. | Director | Common Stock | 0 | $0.39 | Sep 29, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics, Inc. | Oct 1, 2024 | 2 | $0 | 4 | Oct 3, 2024 | Director |
OTLK | Outlook Therapeutics, Inc. | Mar 7, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Director |
OTLK | Outlook Therapeutics, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
TFFP | TFF Pharmaceuticals, Inc. | Sep 29, 2022 | 3 | -$72.1K | 4 | Sep 30, 2022 | Director |
OTLK | Outlook Therapeutics, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 24, 2022 | Director |
TFFP | TFF Pharmaceuticals, Inc. | May 18, 2021 | 1 | $9.87K | 4 | May 19, 2021 | Director |